Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.

@article{Rendon2008SuccessfulTO,
  title={Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.},
  author={Marta I. Rendon and Lina Mar{\'i}a Cardona and Eric W Bussear and Adolfo L. Benitez and Luz E. Col{\'o}n and Lori A. Johnson},
  journal={Cutis},
  year={2008},
  volume={82 5},
  pages={
          372-8
        }
}
Triple-combination (TC) cream is a stable combination of fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05%, and currently is the only US Food and Drug Administration-approved drug for the topical treatment of melasma. Furthermore, it is the only US Food and Drug Administration-approved product containing hydroquinone. Anecdotal evidence suggests that improvements in melasma can be achieved with a multifactor approach involving TC cream with a variety of procedures. A pilot… Expand
Triple combination and glycolic acid peels in melasma in Indian patients
TLDR
Hydroquinone remains the most prescribed bleaching agent worldwide and is still the gold standard for the treatment of hyper pigmentation, although since 2001 its use has been banned in Europe as an ingredient in cosmetics. Expand
Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe Melasma
  • M. Goldman, M. Gold, +4 authors R. Gottschalk
  • Medicine
  • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2011
TLDR
The results of this study suggest that TC cream and IPL treatment is an effective and safe treatment option for patients with melasma. Expand
Treatment of Melasma: systematic review
  • 2010
Introduction: Melasma is an acquired hypermelanosis of sun-exposed areas. The pathophysiology of melasma is uncertain. The most important factor in the development of melasma is exposure to sunlight,Expand
Glycolic acid peel therapy – a current review
  • J. Sharad
  • Medicine
  • Clinical, cosmetic and investigational dermatology
  • 2013
TLDR
Glycolic acid peel is the most common alpha-hydroxy acid peel, also known as fruit peel, which has been found to be very safe with Fitzpatrick skin types I–IV and is a peel that is here to stay. Expand
Evidence-based Review, Grade of Recommendation, and Suggested Treatment Recommendations for Melasma
TLDR
Various ethical, social, logical, regional, and economic issues in the context of Indian and similar populations were given due importance while preparing the suggested therapeutic recommendation. Expand
Melasma: an Up-to-Date Comprehensive Review
TLDR
This review serves as a comprehensive update on the current understanding of the epidemiology, pathogenesis, clinical and histologic features of melasma, as well as treatments for this common, yet therapeutically challenging, condition. Expand
Melasma: Treatment strategy
TLDR
Melasma, a hypermelanosis of the face, is a common skin problem of middle-aged women of all racial groups, especially with dark complexion, and genetic influences, exposure to sunlight, pregnancy, oral contraceptives, estrogen-progesterone therapies, thyroid dysfunction, cosmetics, and drugs have been proposed. Expand
Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial
Melasma is a difficult‐to‐treat hyperpigmentary disorder. While cysteamine is a known potent depigmenting agent, its efficacy in treating melasma has not been tested.
Efficacy and tolerability of chemical peeling as a single agent for melasma in dark‐skinned patients: A systematic review and meta‐analysis of comparative trials
Chemical peelings are used on a wide scale in cosmetic field including melasma treatment. They often provide clinicians with flexibility in tailoring treatments according to patient needs andExpand
The Efficacy of Autologous Nanofat Injection in the Treatment of Infraorbital Dark Colouration
TLDR
Nano fat injections for the treatment of infra orbital dark circles is a simple, cost effectiveprocedure and stem cell activity of the nanofat grafting technique has great potential as a treatment modality for dark circles as well as for skin rejuvenation in general. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 18 REFERENCES
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
TLDR
Two 8-week, multicenter, randomized, investigator-blind studies to compare the efficacy and safety of a hydrophilic cream formulation containing tretinoin 0.05%, hydroquinone 4.0%, and fluocinolone acetonide 0.01% demonstrated that significantly more of the patients treated with RA+HQ+FA experienced complete clearing at the end of week 8. Expand
A Comprehensive Review of the Long-Term and Short-Term Treatment of Melasma with a Triple Combination Cream
  • H. Torok
  • Medicine
  • American journal of clinical dermatology
  • 2006
TLDR
The results of these extensive studies indicate that triple combination cream is efficacious in treating melasma and exhibits a safe profile with low potential for adverse events. Expand
The Combination of Glycolic Acid Peels With a Topical Regimen in the Treatment of Melasma in Dark‐Skinned Patients: A Comparative Study
TLDR
This study demonstrates that serial glycolic acid peels provide an additional effect to a topical regimen which is a modification of the time-tested Kligman's regimen for treating melasma in dark-complexioned individuals if used judiciously and under supervision. Expand
Treatment of melasma.
TLDR
The Pigmentary Disorders Academy undertook to evaluate the clinical efficacy of the different treatments of melasma in order to generate a consensus statement on its management, and concluded that first-line therapy for melasma should consist of effective topical therapies, mainly fixed triple combinations. Expand
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
TLDR
In this study, a once-daily application of TC cream over an extended period of 12 months showed no notable safety concerns and offered an effective treatment for melasma. Expand
Efficacy of Hydroquinone (2%) Versus Tretinoin (0.025%) as Adjunct Topical Agents for Chemical Peeling in Patients of Melasma
  • C. Grover, B. S. Reddy
  • Medicine
  • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2004
TLDR
Hydroquinone is superior to tretinoin as a priming agent in maintaining the results achieved with peels and in decreasing the incidence of postpeel reactive hyperpigmentation. Expand
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.
TLDR
TCT had a 30% better rate of complete clearing than hydroquinone with a lower cost in the U.S. and an incremental cost in other countries, and in every country, cost per primary success was lower for TCT than for Hydroquinone. Expand
The treatment of melasma: a review of clinical trials.
TLDR
Combination therapies such as hydroquinone, tretinoin, and corticosteroids have been used in the treatment of melasma, and are thought to increase efficacy as compared with monotherapy, but their efficacy, safety, or trial design indicates that the interventions would need further study before they could be recommended. Expand
Rationale for the use of topical corticosteroids in melasma.
  • A. Menter
  • Medicine
  • Journal of drugs in dermatology : JDD
  • 2004
TLDR
When used in combination with tretinoin and hydroquinone in the treatment of melasma, fluocinolone acetonide 0.01% suppresses biosynthetic and secretory functions of melanocytes, and thus melanin production, leading to early response inmelasma, synergy among the three agents, and no significant side effects over an 8-week period. Expand
Melasma. Etiologic and therapeutic considerations.
TLDR
In the hierarchy of therapies for melasma, the treating physician must consider the devastating psychosocial impact of pigmentary imperfections within the realm of the benefits and risks associated with each treatment. Expand
...
1
2
...